MITOZANTRONE AS SINGLE AGENT THERAPY IN HEPATOCELLULAR-CARCINOMA - A PHASE-II STUDY

被引：22
作者：
DUNK, AA
SCOTT, SC
JOHNSON, PJ
MELIA, W
LOK, ASF
MURRAYLYON, I
WILLIAMS, R
THOMAS, HC
机构：
[1] UNIV LONDON KINGS COLL HOSP,SCH MED,LIVER UNIT,LONDON SE5 8RX,ENGLAND
[2] CHARING CROSS HOSP,SCH MED,LONDON W6 8RF,ENGLAND
[3] CYANAMID INT RES CTR,RICHMOND TW9 1PJ,SURREY,ENGLAND
来源：
JOURNAL OF HEPATOLOGY | 1985年 / 1卷 / 04期
关键词：
D O I：
10.1016/S0168-8278(85)80777-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：395 / 404
页数：10
相关论文
共 50 条
[31]   PHASE II STUDY OF HIGH-DOSE IFOSFAMIDE IN HEPATOCELLULAR-CARCINOMA [J].
LIN, J ;
SHIU, W ;
LEUNG, WT ;
TAO, M ;
LEUNG, N ;
LAU, WY ;
LI, AKC .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 31 (04) :338-339
[32]   PHASE-II STUDY OF NEOCARZINOSTATIN (NSC 157365) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA [J].
FALKSON, G ;
VONHOFF, D ;
CARBONE, PP .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR) :296-296
[33]   PHASE-II TRIAL OF CHRONIC DAILY VP-16 ADMINISTRATION IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA (HCC) [J].
WIERZBICKI, R ;
EZZAT, A ;
ABDELWARITH, A ;
AYOUB, A ;
KAGEVI, I ;
FADDA, M ;
SIECK, J ;
ABDULKAREEM, M ;
AMIN, T ;
YAZIGI, A ;
FLOCK, M .
ANNALS OF ONCOLOGY, 1994, 5 (05) :466-467
[34]   PHASE-II TRIAL OF ORAL DOXIFLURIDINE PLUS ORAL LEVO-LEUCOVORIN IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA [J].
COLLEONI, M ;
DIBARTOLOMEO, M ;
BAJETTA, E ;
NOLE, F ;
NELLI, P ;
CARNAGHI, C ;
VICARIO, G ;
DELVECCHIO, M ;
BONO, A .
ONCOLOGY REPORTS, 1995, 2 (04) :603-606
[35]   5-FLUOROURACIL AND HIGH-DOSE CALCIUM LEUCOVORIN FOR HEPATOCELLULAR-CARCINOMA - A PHASE-II TRIAL [J].
TETEF, M ;
DOROSHOW, J ;
AKMAN, S ;
COLUZZI, P ;
LEONG, L ;
MARGOLIN, K ;
MORGAN, RJ ;
RASCHKO, J ;
SHIBATA, S ;
SOMLO, G ;
AHN, C .
CANCER INVESTIGATION, 1995, 13 (05) :460-463
[36]   PHASE-II TRIAL OF HIGH-DOSE RECOMBINANT GAMMA-INTERFERON IN ADVANCED HEPATOCELLULAR-CARCINOMA [J].
YOSHIDA, T ;
OKAZAKI, N ;
YOSHINO, M ;
OKHURA, H ;
SHIMADA, Y .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (04) :545-546
[37]   PHASE-II STUDY OF METRONIDAZOLE THERAPY FOR ADVANCED COLORECTAL CARCINOMA [J].
FRYTAK, S ;
MOERTEL, CG ;
CHILDS, DS ;
SCHUTT, AJ ;
ALBERS, JW .
CANCER TREATMENT REPORTS, 1978, 62 (03) :483-485
[38]   SINGLE-AGENT CARBOPLATINUM FOR ADVANCED SEMINOMA - A PHASE-II STUDY [J].
SCHMOLL, HJ ;
HARSTRICK, A ;
BOKEMEYER, C ;
DIECKMANN, KP ;
CLEMM, C ;
BERDEL, WE ;
SOUCHON, R ;
SCHOBER, C ;
WILKE, H ;
POLIWODA, H .
CANCER, 1993, 72 (01) :237-243
[39]   ETOPOSIDE AS A SINGLE AGENT IN RELAPSED ADVANCED LYMPHOMAS - A PHASE-II STUDY [J].
TAYLOR, RE ;
MCELWAIN, TJ ;
BARRETT, A ;
PECKHAM, MJ .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :175-177
[40]   PHASE-II EVALUATION OF SINGLE-AGENT CARBOPLATIN IN ADVANCED THYROID-CARCINOMA [J].
ONG, ST ;
DEGROOT, LJ ;
VOGELZANG, NJ .
ONCOLOGY REPORTS, 1994, 1 (06) :1217-1218
12345